Bank of America’s Achieve Life Sciences ACHV Stock Holding History

Bank of America’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$208K	Buy	70,684 +46,630	+194%	+$207K	﹤0.01%	5344
2025 Q4	$120K	Sell	24,054 -23,355	-49%	-$102K	﹤0.01%	5553
2025 Q3	$149K	Buy	47,409 +13,678	+41%	+$37.5K	﹤0.01%	6412
2025 Q2	$76.2K	Buy	33,731 +9,617	+40%	+$27.4K	﹤0.01%	6643
2025 Q1	$64.4K	Sell	24,114 -12,054	-33%	-$37.5K	﹤0.01%	6669
2024 Q4	$127K	Buy	36,168 +9,760	+37%	+$44.2K	﹤0.01%	6296
2024 Q3	$125K	Buy	26,408 +66	+0.3%	+$302	﹤0.01%	6228
2024 Q2	$124K	Buy	26,342 +3,987	+18%	+$19.2K	﹤0.01%	6152
2024 Q1	$102K	Buy	22,355 +15,823	+242%	+$70.2K	﹤0.01%	6229
2023 Q4	$26.9K	Buy	6,532 +13	+0.2%	+$57	﹤0.01%	6730
2023 Q3	$28K	Hold	6,519	–	–	﹤0.01%	6648
2023 Q2	$33.8K	Buy	+6,519	New	+$45.7K	﹤0.01%	6580
2023 Q1	–	Sell	-16	Closed	-$40	–	7754
2022 Q4	$40	Buy	+16	New	+$41	﹤0.01%	7835
2021 Q4	–	Sell	-46	Closed	–	–	8163
2021 Q3	$0	Buy	+46	New	+$361	﹤0.01%	8067
2021 Q1	–	Sell	-25	Closed	–	–	7381
2020 Q4	$0	Sell	25 -12	-32%	-$102	﹤0.01%	7061
2020 Q3	$0	Buy	+37	New	+$339	﹤0.01%	6850
2020 Q2	–	Sell	-351	Closed	-$2K	–	6795
2020 Q1	$2K	Buy	351 +14	+4%	+$135	﹤0.01%	6616
2019 Q4	$4K	Buy	+337	New	+$7.23K	﹤0.01%	6790
2019 Q2	–	Sell	-13	Closed	-$1K	–	7141
2019 Q1	$1K	Buy	+13	New	+$525	﹤0.01%	6954
2018 Q4	–	Sell	-3	Closed	–	–	7058
2018 Q3	$0	Buy	3 +2	+200%	+$127	﹤0.01%	7232
2018 Q2	$0	Hold	1	–	–	﹤0.01%	7050
2018 Q1	$0	Hold	1	–	–	﹤0.01%	7065
2017 Q4	$0	Hold	1	–	–	﹤0.01%	6996
2017 Q3	$0	Hold	1	–	–	﹤0.01%	7016
2017 Q2	$1K	Hold	1	–	–	﹤0.01%	6792
2017 Q1	$1K	Hold	1	–	–	﹤0.01%	6837
2016 Q4	$1K	Hold	1	–	–	﹤0.01%	6888
2016 Q3	$1K	Hold	1	–	–	﹤0.01%	6904
2016 Q2	$2K	Hold	1	–	–	﹤0.01%	6878
2016 Q1	$1K	Sell	1 -1	-50%	-$1.63K	﹤0.01%	6843
2015 Q4	$4K	Sell	2 -8	-80%	-$33.8K	﹤0.01%	6926
2015 Q3	$52K	Hold	10	–	–	﹤0.01%	5943
2015 Q2	$50K	Hold	10	–	–	﹤0.01%	5938
2015 Q1	$46K	Hold	10	–	–	﹤0.01%	5694
2014 Q4	$49K	Hold	10	–	–	﹤0.01%	6353
2014 Q3	$57K	Sell	10 -22	-69%	-$153K	﹤0.01%	6406
2014 Q2	$260K	Buy	32 +20	+167%	+$246K	﹤0.01%	5303
2014 Q1	$304K	Hold	12	–	–	﹤0.01%	5058
2013 Q4	$221K	Hold	12	–	–	﹤0.01%	5497
2013 Q3	$247K	Hold	12	–	–	﹤0.01%	5272
2013 Q2	$256K	Buy	+12	New	+$268K	﹤0.01%	5385

Other funds holding ACHV

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America's ACHV Position: Q1 2026 in Review

Bank of America increased its Achieve Life Sciences (ACHV) stake by 194% in Q1 2026, buying an estimated $207K and bringing the position to 70,684 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #5344.

Bank of America first reported a position in ACHV in Q2 2013 and has held it in 41 quarters since. The position peaked at $304K in Q1 2014. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

Bank of America held 70,684 shares of Achieve Life Sciences worth $208K as of Q1 2026.
Bank of America bought 46,630 Achieve Life Sciences shares in Q1 2026, an estimated $207K.
Achieve Life Sciences made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5344 holding.
Bank of America first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 41 quarters since.
Bank of America's Achieve Life Sciences position peaked at $304K in Q1 2014.
81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.